Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Diarrhea 1Carcinoma, Medullary 1

Interventions

vandetanib 3selpercatinib 2rovalpituzumab tesirine 1pralsetinib 1Peripheral Blood Stem Cell Transplantation 1Indium 1Imatinib Mesylate 1Filgrastim 1Doxorubicin 1Dexamethasone 1Dacarbazine 1Capecitabine 1Calcium Aluminosilicate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Medullary × Calcium Aluminosilicate × Clear all
NCT01739634 2012-12-03

The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer

Salient Pharmaceuticals Incorporated

Phase 1/2 Unknown
10 enrolled

Diarrhea, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡